Linklaters LLP’s securities litigation defense team is headed from the Washington DC office by Adam Lurie, who often supports multinational companies, financial institutions, and foreign governments. Bringing in the experience of representing several industries, from financial services to software manufacturers, is new partner Muhammad Faridi, who joined the firm in January 2025. Also joining the firm as partners in January 2025 are Adeel Mangi, Diana Conner, and George LoBiondo.
Legal 500 Editorial commentary
Key clients
- Stephen Bond-Nelson, a former Managing Director and Portfolio Manager at Allianz Global Investors U.S. LLC
- Macquarie Investment Management Business Trust
- Dr. Nader Pourhassan, former CEO of a publicly traded biotechnology company, CytoDyn, Inc.
- Ramkumar Rayapureddy, former CIO of pharmaceutical company Viatris Inc. (formerly known as Mylan, Inc.)
- Anthony Martino, the former CFO of Silvergate Bank and other former executives
Work highlights
Representing Ramkumar Rayapureddy, former Chief Information Officer of Viatris, Inc., formerly known as Mylan, Inc. (“Mylan”), a publicly listed global pharmaceutical company headquartered in the U.S. On November 10, 2022, the DOJ unsealed an indictment against Mr. Rayapureddy in the Western District of Pennsylvania, charging him with one count of conspiracy to commit securities fraud and three counts of securities fraud for his alleged role in an insider trading scheme involving the securities of Mylan.
Representing Stephen Bond-Nelson, a former Managing Director and Portfolio Manager at Allianz Global Investors U.S. LLC (“AGI”), in DOJ and SEC actions involving losses suffered by AGI’s Structured Alpha unit in and around March 2020 at the beginning of the COVID-19 pandemic.
Representing Dr. Nader Pourhassan, the former CEO of a publicly traded biotechnology company, CytoDyn, Inc. (“CytoDyn”), in both civil and criminal actions brought by the SEC and the DOJ in the District of Maryland. The respective actions are related to allegations of securities fraud and insider trading during Dr. Pourhassan’s tenure as CEO at CytoDyn.
Practice head
Adam Lurie
Other key lawyers
Doug Davison; Muhammad Faridi; Richard Smith; Douglas Tween; James Warnot; Patrick Ashby; Nicole Jerry; Adeel Mangi; Diana Conner; George LoBiondo.